Horn L - Search Results

1

Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer.

Reck M, Luft A, Szczesna A, Havel L, Kim SW, Akerley W, Pietanza MC, Wu YL, Zielinski C, Thomas M, Felip E, Gold K, Horn L, Aerts J, Nakagawa K, Lorigan P, Pieters A, Kong Sanchez T, Fairchild J, Spigel D. Reck M, et al. Among authors: horn l. J Clin Oncol. 2016 Nov 1;34(31):3740-3748. doi: 10.1200/JCO.2016.67.6601. J Clin Oncol. 2016. PMID: 27458307 Clinical Trial.

2

The rationale for adjuvant chemotherapy in stage I non-small cell lung cancer.

Horn L, Sandler AB, Putnam JB Jr, Johnson DH. Horn L, et al. J Thorac Oncol. 2007 May;2(5):377-83. doi: 10.1097/01.JTO.0000268669.64625.bb. J Thorac Oncol. 2007. PMID: 17473651 Free article.

3

Evarts A. Graham and the first pneumonectomy for lung cancer.

Horn L, Johnson DH. Horn L, et al. J Clin Oncol. 2008 Jul 1;26(19):3268-75. doi: 10.1200/JCO.2008.16.8260. J Clin Oncol. 2008. PMID: 18591561 No abstract available.

4

A phase II study of paclitaxel + etoposide + cisplatin + concurrent radiation therapy for previously untreated limited stage small cell lung cancer (E2596): a trial of the Eastern Cooperative Oncology Group.

Horn L, Bernardo P, Sandler A, Wagner H, Levitan N, Levitt ML, Johnson DH. Horn L, et al. J Thorac Oncol. 2009 Apr;4(4):527-33. doi: 10.1097/JTO.0b013e31819c7daf. J Thorac Oncol. 2009. PMID: 19240650 Free PMC article. Clinical Trial.

5

Angiogenesis in the treatment of non-small cell lung cancer.

Horn L, Sandler AB. Horn L, et al. Proc Am Thorac Soc. 2009 Apr 15;6(2):206-17. doi: 10.1513/pats.200807-066LC. Proc Am Thorac Soc. 2009. PMID: 19349490 Free PMC article. Review.

6

Emerging data with antiangiogenic therapies in early and advanced non-small-cell lung cancer.

Horn L, Sandler AB. Horn L, et al. Clin Lung Cancer. 2009 Mar;10 Suppl 1(Suppl 1):S7-16. doi: 10.3816/CLC.2009.s.002. Clin Lung Cancer. 2009. PMID: 19362948 Free PMC article. Review.

7

EML4-ALK: honing in on a new target in non-small-cell lung cancer.

Horn L, Pao W. Horn L, et al. J Clin Oncol. 2009 Sep 10;27(26):4232-5. doi: 10.1200/JCO.2009.23.6661. Epub 2009 Aug 10. J Clin Oncol. 2009. PMID: 19667260 Free PMC article. No abstract available.

8

Epidermal growth factor receptor inhibitors and antiangiogenic agents for the treatment of non-small cell lung cancer.

Horn L, Sandler A. Horn L, et al. Clin Cancer Res. 2009 Aug 15;15(16):5040-8. doi: 10.1158/1078-0432.CCR-09-0520. Epub 2009 Aug 11. Clin Cancer Res. 2009. PMID: 19671872 Free PMC article. Review.

9

Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer: Eastern Cooperative Oncology Group Study E3501.

Horn L, Dahlberg SE, Sandler AB, Dowlati A, Moore DF, Murren JR, Schiller JH. Horn L, et al. J Clin Oncol. 2009 Dec 10;27(35):6006-11. doi: 10.1200/JCO.2009.23.7545. Epub 2009 Oct 13. J Clin Oncol. 2009. PMID: 19826110 Free PMC article. Clinical Trial.

10

Update on new drugs in small cell lung cancer.

Horn L, Castellanos EL, Johnson DH. Horn L, et al. Expert Opin Investig Drugs. 2011 Apr;20(4):441-5. doi: 10.1517/13543784.2011.553185. Expert Opin Investig Drugs. 2011. PMID: 21395484 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,354 results

Search Page

Filters